Progenics Pharmaceuticals to Present at Upcoming Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Progenics Pharmaceuticals to Present at Upcoming Investor Conferences

TARRYTOWN, N.Y., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq: PGNX ), an oncology company focused on developing innovative ways to target and treat cancer, announced today that Mark R. Baker, CEO, will present at two upcoming investor conferences:

  • Presentation at the BIO CEO & Investors Conference in New York on Monday, February 8, 2016 at 3:30 p.m. Eastern Time
  • Presentation at the RBC Global Healthcare Conference in New York on Tuesday, February 23, 2016 at 11:00 a.m. Eastern Time  

A live webcast of both presentations will be available in the Media Center of the Progenics website,  www.progenics.com . To ensure a timely connection, users should register at least 15 minutes prior to the scheduled start. An archive of the event will be available for 90 days.

About Progenics

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Among the assets in its pipeline of targeted radiotherapy and molecular imaging compounds is AZEDRA™, an ultra-orphan radiotherapy candidate currently in a phase 2 study under an SPA. The Company’s PSMA-targeted product candidates for prostate cancer include two small molecule imaging agents 1404 and PyL, and two therapeutic agents PSMA ADC, an antibody drug conjugate, and 1095, a small molecule radiotherapeutic. Progenics’s first commercial product, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, is partnered with and marketed by Valeant Pharmaceuticals International, Inc.

This press release may contain projections and other "forward-looking statements" regarding future events. Statements contained in this communication that refer to Progenics' estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Progenics' current perspective of existing trends and information as of the date of this communication. Forward looking statements generally will be accompanied by words such as "anticipate," "believe," "plan," "could," "should," "estimate," "expect," "forecast," "outlook," "guidance," "intend," "may," "might," "will," "possible," "potential," "predict," "project," or other similar words, phrases or expressions. Such statements are predictions only, and are subject to risks and uncertainties that could cause actual events or results to differ materially. These risks and uncertainties include, among others, the cost, timing and unpredictability of results of clinical trials and other development activities and collaborations, such as the Phase 3 clinical program for 1404; our ability to successfully integrate Exini Diagnostics AB and to develop and commercialize its products; the unpredictability of the duration and results of regulatory review of New Drug Applications and Investigational NDAs; market acceptance for approved products; the sales of products by our partners and the royalty revenue generated thereby; generic and other competition; the possible impairment of, inability to obtain and costs of obtaining intellectual property rights; possible product safety or efficacy concerns, general business, financial and accounting matters, litigation and other risks and uncertainties detailed in Progenics’ periodic public filings with the Securities and Exchange Commission, including but not limited to Progenics’ Quarterly Report on Form 10-Q for the quarter ended September 30, 2015. More information concerning Progenics and such risks and uncertainties is available on its website, and in its press releases and reports it files with the U.S. Securities and Exchange Commission. Progenics is providing the information in this press release as of today's date and, except as expressly required by law, Progenics disclaims any intent or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or circumstances or otherwise.

Additional information concerning Progenics and its business may be available in press releases or other public announcements and public filings made after this release. For more information, please visit www.progenics.com. Please follow us on LinkedIn®. Information on or accessed through our website or social media sites is not included in the company's SEC filings.

(PGNX-F)

 

Contact: Melissa Downs Investor Relations (914) 789-2801 mdowns@progenics.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 237

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 375

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 245

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 412

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Onewater Marine Shares Hit Bottom as Recovery Efforts Begin

Updated Category News Views 96

Onewater Marine's Stock Reaches 52-Week Low In a challenging year for Onewater Marine (NASDAQ: ONEW) Inc., the company's stock has plummeted to a 52-week low of $18.43. This striking downturn indicates a significant one-year decline, with the stock value decreasing by an alarming 42.49%. Despite this setback, analysts maintain a consensus Buy rating, with price targets...

Continue Reading
Exploring McEwen's Upcoming Results and Strategy Insights

Updated Category News Views 238

Join McEwen for the Q2 2025 Results Conference Call TORONTO — McEwen Inc. (NYSE: MUX) (TSX: MUX) is thrilled to announce an upcoming conference call to discuss the financial results for the second quarter of 2025. This event promises to be an excellent opportunity for shareholders and interested parties to gain insights into the Company’s performance and future...

Continue Reading
Eminent Gold Reinitiates Drilling at Hot Springs Range Project

Updated Category News Views 144

Resuming Drilling at Hot Springs Range Project Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) has resumed core drilling at its Hot Springs Range Project, marking a pivotal moment in its exploration journey. This renewed activity follows the successful completion of its initial drilling campaign, which revealed gold mineralization in multiple holes. The project, situated...

Continue Reading
Exclusive Interview with Donald Trump Aired on FOX Noticias

Updated Category News Views 537

Exclusive Interview Scheduled on FOX Noticias FOX Noticias is set to air an exclusive two-part interview featuring President Donald Trump. The interviews are scheduled for two consecutive days and will be hosted by Rachel Campos-Duffy. This marks a significant moment as it is President Trump's first engagement with the media following notable recent announcements...

Continue Reading
How Immediate Water Filtration Helps Communities Combat Lead Risks

Updated Category News Views 77

Immediate Water Filtration: A Game Changer for Communities In a recent study, experts have highlighted how point-of-use (POU) filtration systems can significantly mitigate lead contamination in drinking water, providing a timely solution for communities grappling with aging infrastructure. This approach is essential, especially as municipalities prepare to comply with...

Continue Reading